Open access
Jul 2026
ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.
Although no emergent safety signals were detected, continued post-marketing surveillance remains imperative, particularly for neurological disorders.
Narges Ebrahimi, P. D. de Whalley, Nasir Kanji et al.
· Vaccine · 0 citations